Title : Fabrication and Evaluation of Celecoxib Oral Oleogel to Reduce the Inflammation of Ulcerative Colitis.

Pub. Date : 2021 Jun 15

PMID : 34129135






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Celecoxib besides its formulae significantly reduced the release of Leucine rich 2 glycoprotein (LRG), Myeloperoxidase (MPO), Tumor necrosis factor-alpha (TNF-alpha), proinflammatory cytokine expression, High mobility group box 1 (HMGB1), Nuclear factor kappa B (NF-KappaB), Trefoil Factor 3 (TFF3), Metalloproteinase-3 (MMP3), and miRNA31. Celecoxib tumor necrosis factor Rattus norvegicus
2 Celecoxib besides its formulae significantly reduced the release of Leucine rich 2 glycoprotein (LRG), Myeloperoxidase (MPO), Tumor necrosis factor-alpha (TNF-alpha), proinflammatory cytokine expression, High mobility group box 1 (HMGB1), Nuclear factor kappa B (NF-KappaB), Trefoil Factor 3 (TFF3), Metalloproteinase-3 (MMP3), and miRNA31. Celecoxib tumor necrosis factor Rattus norvegicus